MAPK1 and RASopathy: Since the BRAF KE mutation induces more marked increases in ERK activity and more severe cognitive disabilities in RASopathy patients, we deemed it worthy of investigation in hopes that the identification of the neurobiological disease mechanisms triggered by this mutation will contribute to our understanding of the cognitive impairments associated with RASopathies.